OPDIVO nivolumab Patient Gateway

OPDIVO nivolumab is a prescription medication. Read about its indications, side effects, and more.

OVERVIEW

This site opdivo.com currently has a traffic ranking of three hundred and forty-nine thousand three hundred and fifty-one (the lower the better). We have evaluated zero pages within the website opdivo.com and found eight websites referencing opdivo.com. We have observed three contacts and addresses for opdivo.com to help you communicate with them. This site opdivo.com has been on the internet for six hundred and eight weeks, thirteen hours, eleven minutes, and fifty-eight seconds.
Traffic Rank
#349351
Links to this site
8
Contacts
3
Locations
3
Online Since
Nov 2012

OPDIVO.COM RANKINGS

This site opdivo.com has seen a alternation quantities of traffic all over the year. Chiefly, the website had a ranking in the past 24 hours of three hundred and forty-nine thousand three hundred and fifty-one.
Traffic for opdivo.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for opdivo.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for opdivo.com

Date Range

All time
This Year
Last Year
Last Month

OPDIVO.COM HISTORY

This site opdivo.com was began on on November 05, 2012. It was updated on February 25, 2014. It will go back on the market on November 05, 2014. As of today, it is six hundred and eight weeks, thirteen hours, eleven minutes, and fifty-eight seconds young.
REGISTERED
November
2012
UPDATED
February
2014
EXPIRED
November
2014

DOMAIN PERIOD

11
YEARS
8
MONTHS
2
DAYS

LINKS TO BUSINESS

BMS Connect

This site is intended for US Healthcare Professionals. This site is intended for US Healthcare Professionals. US Full Prescribing Information including Boxed WARNINGS. You are about to leave this Bristol-Myers Squibb Company site. You are being directed to another Bristol-Myers Squibb Company site. Would you like to leave this page? SUSTIVA Capsule Instructions for Use Video. Would you like to leave this page? Would you like to leave this page? US Full Prescribing Information including Boxed WARNINGS.

OPDIVO nivolumab Information for Healthcare Professionals

This site is intended for U. Give more patients the opdivo. Give more patients the opdivo. For patients with previously treated metastatic Non-Small Cell Lung Cancer. For patients with Metastatic Melanoma. WT patients with Metastatic Melanoma. First-line therapy for patients with. For advanced Renal Cell Carcinoma. For patients with recurrent or metastatic Squamous Cell Carcinoma of the.

OPDIVO nivolumab

It is prescribed to adults who have been previously treated with and progressed on ipilimumab and, if. Positive, ipilimumab and a BRAF inhibitor. It is not known if OPDIVO is safe and effective in children less than 18 years of age.

The Sansone Files The Blog of John A. Sansone

The Blog of John A. Hello faithful followers of this blog. I apologize that it has been a while since my last post. I recently had a CT scan at Cancer Treatment Centers of America. Again, I have been treating at CTCA for two and half years for stage 4 kidney cancer that has spread to both lungs. I am currently being treated with an immunotherapy drug called Opdivo. Cancer Treatment Centers of America.

WHAT DOES OPDIVO.COM LOOK LIKE?

Desktop Screenshot of opdivo.com Mobile Screenshot of opdivo.com Tablet Screenshot of opdivo.com

CONTACTS

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

PO Box 5400

Princeton, NJ, 08543-5400

US

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

HW8A-2.16, PO Box 5400

Princeton, NJ, 08543-5400

US

Bristol-Myers Squibb

Bristol-Myers Squibb

HW8A-2.18, PO Box 5400

Princeton, NJ, 08543-5400

US

OPDIVO.COM HOST

We identified that the main page on opdivo.com took five hundred and seventy-eight milliseconds to load. We detected a SSL certificate, so our crawlers consider this site secure.
Load time
0.578 seconds
SSL
SECURE
Internet Address
13.109.137.206

NAME SERVERS

ns1.bms.com
ns2.bms.com
ns3.bms.com
ns4.bms.com

BOOKMARK ICON

TITLE

OPDIVO nivolumab Patient Gateway

DESCRIPTION

OPDIVO nivolumab is a prescription medication. Read about its indications, side effects, and more.

CONTENT

This site opdivo.com states the following, "This site is intended for U." Our analyzers noticed that the webpage said " residents 18 years of age or older." The Website also stated " This site is intended for U. Residents 18 years of age or older. Go to Healthcare Professional Site. Please choose from the conditions below. With Advanced Non-Small Cell Lung. For Patients With Metastatic Melanoma." The website's header had opdivo as the most important keyword. It was followed by nivolumab, nsclc, and non small cell lung cancer which isn't as highly ranked as opdivo. The next words the site used was metastatic melanoma. renal cell carcinoma was also included but could not be viewed by search crawlers.

MORE WEB SITES

OPDIVO nivolumab Information for Healthcare Professionals

This site is intended for U. Give more patients the opdivo. Give more patients the opdivo. For patients with previously treated metastatic Non-Small Cell Lung Cancer. For patients with Metastatic Melanoma. WT patients with Metastatic Melanoma. First-line therapy for patients with. For advanced Renal Cell Carcinoma. For patients with recurrent or metastatic Squamous Cell Carcinoma of the.

Home Orleans Public Defenders

Client-centered, community-oriented defense for a fair and just New Orleans. New Orleans Second Lines for Equal Justice. Monday, 18 December 2017. For the second year, social justice advocates, criminal justice warriors, community members, and stakeholders together rallied in support of public defense and equal justice in New Orleans. Doing what we do best, we second lined through the streets of New Orleans and called on our leaders to prioritize public defense and criminal justice reform.

OPD MALLECO SUR

La acción de la OPD permite evitar el innecesario e indiscriminado ingreso de niñas, niños y adolescentes al circuito de judicialización e institucionalización. Martes, 22 de febrero de 2011. Jueves, 18 de diciembre de 2008. VIDEO DE CUÑAS RADIALES SOBRE LOS DERECHOS. VIDEO DE LA GRABACION DE LOS PROGRAMAS Y CUÑAS RADIALES.